Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL136314 | Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis | 1 | 2021 |
| R01HL136603 | Pathogenic Role of IL-18 in Sickle Cell Cardiomyopathy and Inducible Ventricular Tachycardia | 1 | 2021 |
| R01HL141826 | Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomics | 1 | 2021 |
| R01LM012535 | Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease | 1 | 2021 |
| R01MH067234 | Effects Of Environmental Challenges On Genetically Modified Interneuronal Subpopulations | 1 | 2021 |
| R01NS101718 | Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke | 1 | 2021 |
| R21AG073710 | Identification of Siglecs as molecular signatures of Disease-Associated Microglia during AD Progression | 1 | 2021 |
| R21AI149205 | The regulation dephosphorylated-CoA-capped RNA and innate immunity by MESH1 | 1 | 2021 |
| R21NS119727 | Mechanisms of capillary-associated microglial interactions | 1 | 2021 |
| R21NS123207 | Novel Targets that Modulate Multiple Adult Models of ALS in Drosophila | 1 | 2021 |
| R35CA197735 | Accelerating Transdisciplinary Epidemiology of Colorectal Cancer | 1 | 2021 |
| R35GM124704 | Defining the epigenetic landscape at single cell resolution | 1 | 2021 |
| R38AI140299 | Emory R38 Research Training Program | 1 | 2021 |
| RF1AG074566 | Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis | 1 | 2021 |
| RF1DA048813 | A novel platform for the investigation of human microglia | 1 | 2021 |
| T32GM008169 | Medical Scientist Training Program | 1 | 2021 |
| T32GM008666 | Training Program in Basic and Clinical Genetics | 1 | 2021 |
| U01AI130830 | Gene Regulation as a Foundation for Autoimmune Disease Prevention | 1 | 2021 |
| U01CA152756 | Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus | 1 | 2021 |
| U01CA214114 | Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=36